Back to Results
First PageMeta Content
Immune system / Pharmaceuticals policy / Immunosuppressants / Natalizumab / Pharmaceutical Benefits Scheme / Interferon beta-1a / Immunology / Multiple sclerosis / Medicine


PBAC Secretariat MDP 952 Department of Health and Ageing GPO Box 9848 Canberra ACT[removed]October 2014
Add to Reading List

Document Date: 2015-03-02 18:33:43


Open Document

File Size: 229,87 KB

Share Result on Facebook

Country

Australia / /

MedicalCondition

MS / disease / /

Organization

Department of Health / Streamlined Authority / /

Person

Matthew Miles / /

Position

Chief Executive Officer / /

Product

Tysabri / Avonex / /

ProvinceOrState

Mississippi / /

SocialTag